Health Care/Hospital

China Xiangtai Food Co., Ltd. Entered into Business Collaboration Agreement for up to RMB35,000,000 to Expand Operation Scale and Diversify Distribution Channels

CHONGQING, China, Feb. 25, 2020 /PRNewswire/ -- China Xiangtai Food Co. Ltd. (NASDAQ: PLIN) (the "Company" or the "PLIN"), an emerging growth company primarily engaged in pork processing inChina, today announced that the Company, through its primary operating subsidiary Chongqing Penglin Food Co....

2020-02-25 21:30 5907

United Imaging's Emergency Radiology Departments Support Mobile Cabin Hospitals, Facilitate 5G Remote Diagnosis

SHANGHAI, Feb. 25, 2020 /PRNewswire/ -- At the center of the epidemic in Wuhan, many sports centers, exhibition halls, and schools have been turned into mobile cabin hospitals (MCHs) to treat tens of thousands of coronavirus patients with mild symptoms. During the epidemic, fast and accurate CT d...

2020-02-25 21:00 1742

Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Trial of APG-1387 in Combination with Chemotherapy for the Treatment of Advanced Pancreatic Cancer in China

SUZHOU, China and ROCKVILLE, MD., Feb. 24, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company has receive...

2020-02-24 22:00 2367

Yili supports pastures amid coronavirus outbreak

HOHHOT, China, Feb. 24, 2020 /PRNewswire/ -- In the wake of the novel coronavirus outbreak, dairy giant Yili Industrial Group has raised670 million yuan ($95.7 million) in order to help its cooperative pastures, while providing anti-epidemic guidance and opening up fast track financing channels f...

2020-02-24 18:47 1208

Emergency Service from 111 Helps Companies Secure Epidemic Supplies to Open for Business

SHANGHAI, Feb. 24, 2020 /PRNewswire/ -- Businesses across China need to secure epidemic supplies such as face masks and disinfectant to re-open factories and offices. Now they will be able to turn to 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthca...

2020-02-24 16:00 4213

WuXi Biologics Congratulates Immutep on Positive Interim Data for IMP-321

SHANGHAI, Feb. 23, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, congratulates its strategic partner Immutep, a biotechnology comp...

2020-02-24 08:00 6050

Enterprises Resume Work and Production in Xi'an, China amid Novel Coronavirus Outbreak

XI'AN, China, Feb. 21, 2020 /PRNewswire/ -- As China continues to tackle the n ovel coronavirus outbreak, its industries have started to return to work in an orderly manner.Xi'an, one of the national central cities and an important scientific research, educational and industrial base inChina, has ...

2020-02-21 19:36 2057

Yum China Stands with Communities to Fight Coronavirus

SHANGHAI, Feb. 20, 2020 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China") (NYSE: YUMC) today announced that it has been actively mobilizing resources in a multi-pronged response to the outbreak of novel coronavirus (COVID-19). As part of its efforts, the Company immediately ...

2020-02-21 09:54 12041

VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update

AUSTIN, Texas, Feb. 20, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the full fiscal year endedDecember 31, 2019. Volition management will host a conference call tomorrow,February 21, at 8:30 a.m. U.S. Easte...

2020-02-21 05:10 10072

StoneWise AI-driven Drug Discovery Platform: Investigation and Repurpose of Nucleoside-based RNA Polymerase Inhibitors and Their Potential Use in COVID-19 Infection Treatment

BEIJING, Feb. 20, 2020 /PRNewswire/ -- In a campaign to screen drugs for the treatment of COVID-19, the disease caused by SARS-CoV-2, StoneWise, a company specialized in applying artificial intelligence to innovative drug design solutions for innovative drug R&D enterprises and institutions, has ...

2020-02-20 20:04 1383

111 to Announce Fourth Quarter and Fiscal Year 2019 Unaudited Financial Results on March 12, 2020

SHANGHAI, Feb. 20, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform inChina , today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2019 endedDecember 31, 2019, bef...

2020-02-20 17:15 10280

111 Partners with Financial Institutions in Battle Against Coronavirus

SHANGHAI, Feb. 20, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI, "111" or the "Company") has announced that it will leverage its knowhow and technology in the battle against the novel coronavirus (COVID-19) public health crisis, through partnerships with some ofChina's leading financial institution...

2020-02-20 17:00 5305

Ten billion investment to build Chengdu medical city to create a new highland for the international health industry

CHENGDU, China, Feb. 20, 2020 /PRNewswire/ -- In 2019, with the continuous advancement of "three medical integration", Chengdu Medical City's three medical innovation center, as "Western China Biomedical Innovation Center", submitted a satisfactory answer sheet: 58 new contracted projects (47 thr...

2020-02-20 16:04 730

Industrial enterprises in Weifang, Shandong resume work and production while fighting epidemic

WEIFANG, China, Feb. 20, 2020 /PRNewswire/ -- In order to respond to the epidemic of novel coronavirus pneumonia (NCP), the government ofShandong Province has issued a notice that requires enterprises that are key to national economy and people's livelihoods to immediately resume work and product...

2020-02-20 13:37 1247

VolitionRx Limited Schedules Full Year 2019 Earnings Conference Call and Business Update

AUSTIN, Texas, Feb. 18, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call onFriday, February 21 at 8:30 a.m. Eastern time to discuss its financial and operating results for the fourth quarter and full year 2019, in conjunctio...

2020-02-19 05:10 10216

Mankind should share sorrows when facing COVID-19

BEIJING, Feb. 18, 2020 /PRNewswire/ -- A news report by China.org.cn on some Western media's virus-related xenophobic comments againstChina:   The 2019 novel coronavirus disease (COVID-19) is currently under the spotlight around the world, with cases having been confirmed in ove...

2020-02-19 00:13 1262

Transcenta Achieves Major Milestone in Continuous Perfusion Cell Culture Platform to Provide Industry Leading Productivity and Speed to Manufacturing

SUZHOU and HANGZHOU, China, Feb. 18, 2020 /PRNewswire/ -- Transcenta, a global biotherapeutics company that fully integrates antibody-based biotherapeutics discovery, R&D, regulatory affairs and manufacturing, today announced it has achieved a major milestone in its continuous perfusion cell cult...

2020-02-19 00:00 731

Henlius successfully held its fourth Scientific Advisory Board (SAB) meeting

SHANGHAI, Feb. 18, 2020 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK, Henlius), a global biologics company specialized in the discovery and development of high-quality and affordable antibodies for the treatment of patients with cancer and autoimmune diseases, recently held its fourth ...

2020-02-18 21:59 6458

Volition Unveils Its Epigenetic Toolbox

AUSTIN, Texas, Feb. 18, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that research on its Nu.Q(TM) Capture program has led to the development of a suite of novel epigenetic tools building on the breakthroughs announced last month on its assay platform...

2020-02-18 21:30 8578

Ally Bridge Group Leads US$70 million Investments in Two Israeli Life Science Companies over the Last 2 Months

TEL AVIV, Israel, HONG KONG and NEW YORK, Feb. 18, 2020 /PRNewswire/ — Ally Bridge Group ("ABG"), a leading global life science investment group, has announced that it recently ledUS$70 million investments in two Israeli life science companies over the last 2 months. Each of the two companies is ...

2020-02-18 21:30 1702
1 ... 255256257258259260261 ... 269